Spain, Italy and Greece respectively were numbers 2, 3 and 4 in this ranking.
How does Latvia perform in Antidiabetics?
Forecast: Systemic Hormonal Preparations Sales (Excluding Sex Hormones and Insulins) in Latvia
- Million US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Diabetes Medicine Sales in Latvia
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Diabetes Medicine Sales in Latvia
- Million US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Systemic Hormonal Preparations Use (Excluding Sex Hormones and Insulins) in Latvia
- Units (Defined Daily Dosage) Per Thousand Persons Per Day
- 2024 to 2028
- ReportLinker Research
Forecast: Systemic Hormonal Preparations Sales (Excluding Sex Hormones and Insulins) in Latvia
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Systemic Hormonal Preparations Sales (Excluding Sex Hormones and Insulins) in Latvia
- Million Euros
- 2024 to 2028
- ReportLinker Research
Forecast: Systemic Hormonal Preparations Sales (Excluding Sex Hormones and Insulins) in Latvia
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Diabetes Medicine Sales in Latvia
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Diabetes Medicine Sales in Latvia
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Systemic Hormonal Preparations Sales (Excluding Sex Hormones and Insulins) in Latvia
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research